ResMed Inc. (NYSE:RMD) Q3 2025 Earnings Call Transcript April 23, 2025
ResMed Inc. misses on earnings expectations. Reported EPS is $2.37 EPS, expectations were $2.38.
Operator: Greetings, and welcome to the Q3 Fiscal Year 2025 ResMed Earnings Conference Call. My name is Kevin, and I will be your operator for today’s call. At this time, all participants are in a listen-only mode. Also, please note this conference call is being recorded. Later, we will conduct a question and answer session....
